Dr. Samir A. Shah is a Clinical Professor of Medicine at the Alpert Medical School at Brown University in Providence, RI and Chief of Gastroenterology at the Miriam Hospital. He is a partner with Gastroenterology Associates, Inc, a private practice GI group affiliated with Brown.
Dr. Shah earned his BA in Biochemistry magna cum laude at Brown and his MD at Harvard Medical School in Boston, MA. After graduating, he completed his residency in Internal Medicine at the Harvard-affiliated Beth Israel Deaconess Medical Center. He continued on for a fellowship in Gastroenterology at the same institution where he was awarded a Howard Hughes Postdoctoral Fellowship for Physicians and spent two years in the laboratory studying murine models of Inflammatory Bowel Disease.
Dr Shah has authored or co-authored more than 100 articles/book chapters/abstracts and has given over 100 invited presentations primarily devoted to inflammatory bowel disease. Dr. Shah is the recipient of numerous honors and awards, including Brown University’s Teaching Recognition Award, The Dean’s Teaching Excellence Certificate, Brown University’s Excellence in Teaching Award for Clinical Faculty, the Beckwith Family Award for Outstanding Teaching, the American College of Gastroenterology’s Freshman Governor’s Award and later the William D. Carey Award. The New England Chapter of the Crohn’s and Colitis Foundation named him Humanitarian of the Year for 2009. Rhode Island Monthly consistently names him among the Top Doctors in Rhode Island.
He currently serves as co-chair of the Membership Committee of the Crohns and Colitis Foundation and previously served as co-chair of the Professional Education Committee. He serves as co-chair of the IBD-Circle, an online community sponsored by the Crohns and Colitis Foundation and the ACG. He has been one of the ACG representatives to the Digestive Diseases National Coalition (DDNC) and in December 2018 became President of the DDNC. He has served on the Board of Trustees for the American College of Gastroenterology since 2005 and is currently the Vice President of ACG. He has participated in several multi-center clinical trials of cutting-edge therapies for IBD, was co-principal investigator for OSCCAR (Ocean State Crohn’s and Colitis Area Registry). His group participates in the IBD QORUS program through the Crohn's and Colitis Foundation.